NAN-190

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNAN-190

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsSerotonin 1a (5-HT1a) receptor antagonists

TargetsSerotonin 1a (5-HT1a) receptorAdrenergic receptors alpha-1

Therapy Area/IndicationsDepressive Disorder, MajorAnxiety DisordersHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovo Nordisk A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsDepressive Disorder, MajorAnxiety DisordersHypertension

ATC CodeN/A